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TLC densitometric method for screening of lycopsamine 
in comfrey root (Symphytum officinale L.) extracts using
retrorsine as a reference compound
Due to severe toxicity of pyrrolizidine alkaloids, their quan-
ti­fication­in­medicinal­products­is­very­important.­The­idea­
of this research was to use retrorsine as a surrogate refer-
ence compound instead of lycopsamine reference or lyco-
psamine isolated from comfrey. A method for the analysis 
of lycopsamine in extracts of comfrey roots was developed 
and validated, employing thin layer chromatography, deri-
vatisation­with­Dann-Mattocks­reagent­followed­by­densi-
tometric­analysis.­The­new­method­showed­linearity­with-




comfrey root and comfrey root medicinal products such as 
ointments.
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copsamine, intermedine, their acetylated derivatives and symphitine. Pyrrolizidine alka-
loids­are­metabolised­in­humans­to­hepatotoxic­and­pulmotoxic­pyrrole­derivatives­(2–4)­
in­a­reaction­catalysed­by­CYP­3A4­(5,­6).­Because­of­their­high­toxicity,­it­is­of­interest­to­
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a Partial results of this research were presented at the 57th­International­Congress­and­Annual­Meeting­of­the­
Society­for­Medicinal­Plant­and­Natural­Product­Research­in­Geneva,­Switzerland,­in­2009.
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employing­ readily­ commercially­ available­ alkaloid­ retrorsine­ as­ a­ surrogate­ reference­
compound for lycopsamine, which is actually present in the plant.
EXPERIMENTAL
























Solutions of reference compounds
Solutions of retrorsine commercial compound (1.00 and 0.100 mg mL–1) and lycops ami-
ne­trifluoroacetate­(0.946­and­0.0946­mg­mL–1,­corresponding­to­0.684­and­0.0684­mg­mL–1 
lycopsamine,­ respectively)­were­prepared­by­dissolving­ them­ in­methanol­ and­ subse-
quently diluting with methanol.
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Thin layer chromatography
Samples­were­applied­to­TLC­plates­using­a­Linomat­IV­at­a­speed­of­5­mL s–1 in the 
form­of­10-mm­bands.­Applied­volumes­were­from­3­to­10­μL­and­the­respective­masses­of­












scanning speed 5 mm s–1, data resolution 100 mm per step, wavelength 550 nm, second 
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Repeatability within the TLC plate
Repeatability­within­the­TLC­plate­was­assessed­by­seven­replicate­analyses­of­stan-





μg for lycopsamine, with respective R2­values­of­0.999­and­0.991.­For­limits­of­detection­
(LOD) and quantitation (LOQ), a signal-to-noise ratio (S/N) of 3 and 10 was considered, 










Since the signals of lycopsamine and retrorsine are not completely separated and are 
not­additive,­retrorsine­cannot­be­used­as­an­internal­reference­standard.­It­was,­however,­
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compound.­Quantification­of­lycopsamine­was­done­using­retrorsine­as­an­external­sur-
rogate reference compound as well lycopsamine reference compound and was selective 
(see­typical­TLC­chromatogram­in­Fig.­2).­The­concentration­of­lycopsamine­in­comfrey­





and uses an external surrogate reference compound (retrorsine) instead of the generally 
unavailable­and­expensive­lycopsamine.­Several­factors­indicated­suitability­of­retrorsine­
as a surrogate reference compound in the same range of concentrations as lycopsamine: 
comparison­of­UV­spectra­of­high­similarity,­close­retardation­factors,­very­similar­re-
sponses­of­derivatised­alkaloids.­However,­due­to­its­low­precision,­the­method­is­suitable­
only for preliminary estimation of lycopsamine.
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